[1]  Akari, P., Chatterjee, C., & Higgins, M. J. (2024). Don’t Throw the Baby Out With the Bathwater: Firm Response to Downstream Product Shocks (NBER WP No. w32703). (Revise & resubmit, Management Science).


[2]  Mahendiran, S. Chatterjee, C., Dukes, J. Anthony, Sokol, D. Daniel. (2024). Signalling Toughness through Corporate Trademark Litigation: Evidence from India (Revise & resubmit, Research Policy). 


[3]  Agrawal, S., Rathi, S., Chatterjee, C., & Higgins, M. J. (2024). Do Stronger IPR Incentivize Female Participation in Innovation? Evidence from Chinese AI Patents (NBER WP No. w32547). (under review).


[4]   Cao, S., & Chatterjee, C. (2024). Equilibrium effects of pharmaceutical bundling: Evidence from India. SIEPR (Stanford) Working Paper 22-03.


[5]  Chatterjee, C. Fan, Ying, Mohapatra, D. M. (2024). Spillover Effects in Complementary Markets: A Study of the Indian Cellphone and Wireless Service Markets. Working Paper.


[6]  Chatterjee, C. Hanushek. Eric. A. & Mahendiran. Shreekanth. (2024). Can Greater Access to Education Be Inequitable? New Evidence from India’s Right to Education Act. NBER WP No. w27377.


[7]  Chakrabarti, A. S., Chatterjee, C. & Gupta, S. (2024). Demonetization and Healthcare Expenditure (under review). 


[8] Agrawal, S., Bhattacharya, S., Chatterjee, S. & Chatterjee, C. (2024). Income shock and Women’s Health Spending: Evidence from India (under review). Sussex Economics WP No. 13-2024. 


*** Note: Email chirantan@gmail.com or access SSRN page for latest drafts. This space will be regularly updated with other upcoming projects.